Insider Sale: Chief Medical Officer of $PCRX (PCRX) Sells 879 Shares
Insider Sale: Chief Medical Officer of $PCRX (PCRX) Sells 879 Shares
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.JONATHAN SLONIN, the Chief Medical Officer of $PCRX ($PCRX), sold 879 shares of the company on 01-06-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares. Following this trade, they now own 93,443 shares of $PCRX stock.
約翰·斯洛寧（JONATHAN SLONIN），$PCRX（$PCRX）的首席醫療官，於2025年1月6日出售了879股該公司的股票。我們從最近的SEC備案中收到了有關這筆交易的數據。這筆交易大約佔他們持有股份的0.9%。在這次交易之後，他們現在持有93,443股$PCRX股票。
$PCRX Insider Trading Activity
$PCRX內部交易活動
$PCRX insiders have traded $PCRX stock on the open market 10 times in the past 6 months. Of those trades, 6 have been purchases and 4 have been sales.
$PCRX內部人士在過去6個月內在公開市場上交易了10次$PCRX股票。在這些交易中，有6次是購買，4次是銷售。
Here's a breakdown of recent trading of $PCRX stock by insiders over the last 6 months:
以下是過去6個月內部人士對$PCRX股票的近期交易彙總：
- JONATHAN SLONIN (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,824 shares.
- DARYL GAUGLER (Chief Operating Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,000 shares.
- MARCELO BIGAL has traded it 2 times. They made 2 purchases, buying 4,912 shares and 0 sales.
- LAURA BREGE purchased 1,000 shares.
- MICHAEL J. YANG purchased 2,000 shares.
- MARK FROIMSON purchased 1,400 shares.
- FRANK D. LEE (Chief Executive Officer) purchased 8,264 shares.
- 約翰·斯洛寧（首席醫療官）交易了2次。他們沒有購買，進行了2次銷售，出售了1,824股。
- 達里爾·高格勒（首席運營官）交易了2次。他們沒有購買，進行了2次銷售，出售了1,000股。
- 馬塞洛·比加爾（MARCELO BIGAL）交易了2次。他們進行了2次購買，購買了4,912股，0次銷售。
- 勞拉·佈雷格（LAURA BREGE）購買了1,000股。
- MICHAEL J. YANG 購買了2000股。
- MARk FROIMSON 購買了1400股。
- FRANk D. LEE （首席執行官）購買了8264股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟蹤內部交易，請查看Quiver Quantitative的內部交易儀表。
$PCRX Hedge Fund Activity
$PCRX 對沖基金活動
We have seen 131 institutional investors add shares of $PCRX stock to their portfolio, and 154 decrease their positions in their most recent quarter.
我們已經看到131家機構投資者在最近一個季度增加了PCRX股票的持倉，而154家減少了其持倉。
Here are some of the largest recent moves:
以下是最近的一些重大變動：
- PACER ADVISORS, INC. added 2,799,434 shares (+129.4%) to their portfolio in Q3 2024
- FRONTIER CAPITAL MANAGEMENT CO LLC removed 1,836,873 shares (-100.0%) from their portfolio in Q3 2024
- MACQUARIE GROUP LTD removed 1,567,013 shares (-100.0%) from their portfolio in Q3 2024
- D. E. SHAW & CO., INC. added 1,476,508 shares (+307.3%) to their portfolio in Q3 2024
- STEPHENS INVESTMENT MANAGEMENT GROUP LLC removed 1,371,561 shares (-100.0%) from their portfolio in Q3 2024
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,099,216 shares (+2058.1%) to their portfolio in Q3 2024
- MORGAN STANLEY added 1,079,724 shares (+209.2%) to their portfolio in Q3 2024
- PACER ADVISORS, INC. 在2024年第三季度增加了2,799,434股（+129.4%）的持倉。
- FRONTIER CAPITAL MANAGEMENT CO LLC 在2024年第三季度從其投資組合中移除了1,836,873股（-100.0%）。
- MACQUARIE GROUP LTD 在2024年第三季度從其投資組合中移除了1,567,013股（-100.0%）。
- D. E. SHAW & CO., INC. 在2024年第三季度向其投資組合中增加了1,476,508股（+307.3%）。
- STEPHENS INVESTMENT MANAGEMENT GROUP LLC 在2024年第三季度從其投資組合中移除了1,371,561股（-100.0%）。
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 在2024年第三季度向其投資組合中增加了1,099,216股（+2058.1%）。
- 摩根士丹利 在2024年第三季度向其投資組合中增加了1,079,724股（+209.2%）。
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟蹤對沖基金的股票投資組合，請查看Quiver Quantitative的機構持有情況儀表。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不是金融建議。有關更多信息，請參閱Quiver Quantitative的免責聲明。
